Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 October 2003

Bronchoalveolar lavage with saline surfactant solution in the treatment of neonates with severe respiratory failure due to MAS,PIE,or BPD

Iwona Maroszyńska, Jarosław Wilkowski, Jacek Czop, Tomasz Dygas

Med Sci Monit 2003; 9(5): 22-28 :: ID: 428683

Abstract

Background: To assess of the safety and efficacy of tracheobronchial lavage with natural surfactant solution in term newborns with meconium aspiration syndrome (MAS)and preterm neonates with pulmonary interstitial emphysema (PIE),or bronchopulmonary dysplasia (BPD). Material/Methods: Neonates received 20 ml/kg of natural surfactant saline solution at concentration 5 mg phospholipid/ml.Analysis of oxygenation index (OI)and arterial-alveolar ratio (A-a DO 2 )were performed directly before the procedure and within 0,1,2,12,24, 48,72 hours after lavage.We compared values of FiO 2 ,MAP,PIP,pH,SpO 2 ,PaCO 2 ,OI,AaDO 2 ,before and after lavage.Results: We treated 29 neonates (11 with MAS,16 with BPD and 2 with PIE).In neonates with MAS there was a decrease of OI and AaDO 2 at 2,12,24,48 and 72h after lavage. Ventilatory settings necessary to keep PaO 2 and CO 2 in normal range at 24,48 and 72 hour after lavage were significantly lower when compared with baseline.In the neonates with BPD there was a drop of OI from 8.1 to 3.5 24 hours after the procedure,and of AaDO 2 from 808.4 mmHg to 134.2 mmHg in the same time interval. Neonates were extubated between 1 to 38 (mean 11.87)days after lavage.It was noticed that OI and A-aDO 2 at 24 and 48 hours after proce- dure had the greatest prognostic value.Conclusions: Surfactant lavage of bronchoalveolar tree is a safe procedure and may be effective in the treatment of neonatal MAS, PIE and BPD.

Keywords: surfactant, neonate,, Meconium, BPD, lavage

Add Comment 0 Comments

Editorial

01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

Clinical Research  

Comparative Efficacy of Micro-Needle-Knife Therapy and Acupuncture in Acute Ankle Sprains: A Randomized Con...

Med Sci Monit In Press; DOI: 10.12659/MSM.944157  

0:00

Clinical Research  

The Influence of Gestational Diabetes Mellitus on Maternal and Neonatal Outcomes: A Retrospective Study in ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943644  

0:00

Clinical Research  

Exploring the Educational Social and Physical Activities Among Health Care Undergraduates – a Cross-Section...

Med Sci Monit In Press; DOI: 10.12659/MSM.943399  

Clinical Research  

Percutaneous Coronary Intervention as a Non-Surgical Treatment for Ischemic Mitral Regurgitation in Patient...

Med Sci Monit In Press; DOI: 10.12659/MSM.943122  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750